chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2nd dose of Moderna given after expriation of 9/25/201 per health system.; patient's 2nd had undergone a temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2nd dose of Moderna given after expriation of 9/25/201 per health system.) and PRODUCT TEMPERATURE EXCURSION ISSUE (patient's 2nd had undergone a temperature excursion) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy. Concomitant products included CELECOXIB, ESTRADIOL, FOLIC ACID, HYDROXYCHLOROQUINE, AMITRIPTYLINE, IPRATROPIUM, METHOTREXATE, OMEPRAZOLE, PHENTERMINE, MACROGOL 3350 (MIRALAX) and PROGESTERONE (PROMETRIUM [PROGESTERONE]) for an unknown indication.    On 27-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (2nd dose of Moderna given after expriation of 9/25/201 per health system.) and PRODUCT TEMPERATURE EXCURSION ISSUE (patient's 2nd had undergone a temperature excursion). At the time of the report, EXPIRED PRODUCT ADMINISTERED (2nd dose of Moderna given after expriation of 9/25/201 per health system.) outcome was unknown and PRODUCT TEMPERATURE EXCURSION ISSUE (patient's 2nd had undergone a temperature excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported. dose 1 start date 30-08-2021 and route intramuscular right deltoid batch number 038b21A   Most recent FOLLOW-UP information incorporated above includes: On 30-Sep-2021: Significant follow up received Dose 1 details added in I narrative , concomitant medications, event  and Allergy added.
In addition to Reference report no, I would like to report numbness on hands and feet still has not gone away despite the doctor said it will go away itself.
Patient received a expired vaccine 16Apr2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a expired vaccine 16Apr2022) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007J21-2a) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy.    On 20-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a expired vaccine 16Apr2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received a expired vaccine 16Apr2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  It was reported that the patient never had COVID positive test or diagnosis and patient didn't received any other vaccines within 1 month prior to Moderna COVID-19 vaccine.  No treatment medication information was provided.   This case was linked to MOD-2022-549135, MOD-2022-549157, MOD-2022-549136 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Apr-2022: Follow-up received on 25-Apr-2022:.Reporter information and patient details updated.
Next day had dizziness and increased dizziness the following day. Friday had redness at injection site size of dime. Dizziness increased when standing or while turning head when sitting.
Information has been received from a pharmacist referring to a patient of unkonwn age and gender. The patient's concurrent conditions, concomitant medication and medical history were not provided. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiry date, dose and route were unspecified). On an unknown date the patient developed a case of Shingles on an unspecified date following the administration of ZOSTAVAX. The outcome of the event was not provided. Additional information has been requested.
No additional AE; A patient was given an expired dose of PNEUMOVAX23 which was given 28-JAN-2022; This spontaneous report has been received from an office manager, concerning to an unknown gender and age patient. No information was provided regarding the patients' pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies.  On 28-JAN-2022, the patient was vaccinated with an expired pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) syringe at a dose of 0.5 milliliters (mL) (lot number T009743 has been verified to be a valid lot number, expiration date reported and established as 27-JAN-2022) as prophylaxis (vaccination scheme frequency, route of administration, and anatomical location of vaccination were not provided) (expired product administered). No additional adverse events (AE) reported (no adverse event).
Developed large red and swollen welt on my left arm. Within 24 hours the welt grew to 6 inches long and was raised about 1/4 inch high. It took over a week and a half to heal.
Shingles after dose 1; Sick after first dose; 2nd dose has not been administered yet; This case was reported by a other health professional via call center representative and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In January 2020, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles, sickness and incomplete course of vaccination. On an unknown date, the outcome of the shingles, sickness and incomplete course of vaccination were unknown.   The reporter considered the shingles and sickness to be unrelated to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter reported that the patient received dose of Shinngrix vaccine and felt sick (unknown cause) and experienced shingles.  The patient did not receive the 2nd dose till the time of reporting, which led to incomplete course of vaccination. It was unknown what symptoms the patient experienced. The reporter did not have additional information during the call. The reporter did not what kind of sick the patient was or what symptoms the patient had. The reporter consented to follow-up via postal mail. The reporter not believed that the Shingrix caused the patient's symptoms.
Patient presented to PCP from group home residency on 05/21/21 with C/O cough, dyspnea, fever, chills, and body aches.  Known exposure to COVID-19.  Rapid test in PCP office was positive for COVID-19.  Chest Xray showed pneumonia.  Patient admitted to hospital on 05/21/21
Patient experienced swelling and redness after immunization. Patient stated that these symptoms were uncommon to her. Two days later patient was diagnosed with cellulitis.
May 2nd I woke up with dizziness until today May 4th, I can't stay stand much time because I get so dizzy.; May 2nd I woke up with dizziness until today May 4th, I can't stay stand much time because I get so dizzy.; I felt the face warm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01May2021 11:00 (Batch/Lot number: unknown) at the age of 31 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING HOT (non-serious) with onset 01May2021 10:00, outcome "not recovered", described as "I felt the face warm"; DIZZINESS (non-serious) with onset 02May2021 10:00, outcome "not recovered", DYSSTASIA (non-serious) with onset 04May2021 10:00, outcome "not recovered" and all described as "May 2nd I woke up with dizziness until today May 4th, I can't stay stand much time because I get so dizzy.". Therapeutic measures were not taken as a result of feeling hot, dizziness, dysstasia.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, has the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The patient received an expired covid vaccine at an outpatient clinic, Urgent Care. The vial expired on 7/31/22 per extended shelf-life. The current process is covid vaccines are shipped to main hospital campus and stored in freezer. The Clinic Manager or designated leader from Urgent Care was picking up covid vaccines weekly or as needed to distribute to Urgent Care clinics. The Clinic Manager would store the vials in the refrigerator at Urgent Care to be ready to use. The nurse would pull vial from refrigerator to administer to patient.
abnormally large bump under armpit (swollen lymph node), has not resolved but pain has decreased with Motrin .  along with the usual fever, ST, cough, chills, sweats and severe HD on the LT temporal area behind the eye.
Headache, Myalgia,  CHILLS; INJECTION SITE REACTION Narrative:
rash at injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE RASH (rash at injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (rash at injection site). At the time of the report, VACCINATION SITE RASH (rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. Treatment medication was not provided.
27May21 approximately 5:45 P.M had blacked out fell down approximately 10 stairs paramedics was called taken to ER admitted on 27May21 CT showed bilateral pulmonary embolism without; 27May21 approximately 5:45 P.M had blacked out fell down approximately 10 stairs paramedics was called taken to the hospital, admitted on 27May21. CT showed bilateral pulmonary embolism without; 27May21 approximately 5:45 P.M had blacked out fell down approximately 10 stairs paramedics  was called taken to hospital and admitted on 27May21 CT showed bilateral pulmonary embolism without; This is a spontaneous report received from a contactable consumer (patient) reported for himself. A 68-years-old male patient received second dose of BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0168, Expiration date: unknown) via an unspecified route of administration, administered in right arm on 26May2021 at 12:15 pm (age at vaccination was 68 years) as 2nd dose, single for COVID-19 immunization. The patient did not have any medical history and known allergies. The patient did not receive concomitant medications or any other medications within 2 weeks of vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0176, Expiration date: unknown) via an unspecified route of administration, administered in right arm on 05May2021 at 12:15 pm (age at vaccination was 68 years) as 1st dose, single for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 27May2021 approximately 5:45 pm, the patient had blacked out fell down approximately 10 stairs paramedics was called taken to withheld admitted on 27May2021. CT showed bilateral pulmonary embolism without right heart strain. The adverse events resulted in Emergency room/department or urgent care and hospitalization. The patient was hospitalized for 4 days from 27May2021 to 31May2021. The patient received the treatment with Eliquis for the adverse events. Since the vaccination, the patient has been tested for COVID-19 which included nasal swab Coronovirus Sar-Cov-2 test on 28May2021, and the result was negative. The device date and device timestamp date was reported as 12Jun2021. The events were reported as serious (hospitalization). The outcome of the events was resolving.  Information on Lot/Batch number was available. Additional information has been requested.
COMPLAINED OF PAIN AND TINGLING IN LEFT ARM POST FLU SHOT.  SYMPTOMS DID NOT BEGIN UNTIL SEVERAL DAYS TO A WEEK AFTER SHE RECEIVED THE SHOT.
redness; swollenness; warm feeling in the same arm.; soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness), PAIN IN EXTREMITY (soreness in the arm), SWELLING (swollenness) and FEELING HOT (warm feeling in the same arm.) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness in the arm). On 02-Apr-2021, the patient experienced ERYTHEMA (redness), SWELLING (swollenness) and FEELING HOT (warm feeling in the same arm.). At the time of the report, ERYTHEMA (redness), SWELLING (swollenness) and FEELING HOT (warm feeling in the same arm.) outcome was unknown and PAIN IN EXTREMITY (soreness in the arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
3 Am 01/07/21 Body Aches. 2x Tylenol. 10Am Dizzy, Confised, Achy. Fever 99.6, BP Elevated. 2x Tylenol. 3PM Fever 101.6 2x Tylenol, Methocarbamol 750mg . Continued as needed.  6AM 01/08/2021 Fever,  Achy, Left Arm Pit swollen and hurt to touch. Continued Tylenol and Methocarbamol as needed. Achyness subsided evening of 01/08/21 Arm pit still swollen & sore to touch. 01/09/21 Swelling down in arm pit only sore to touch. Fever Blister now present in and around nose and upper lip. Tylenol as needed. 01/10/21 Feverblisters and gingiva in mouth sore.
A pharmacist reported that a patient received  a tetanus injection 44 years ago and experienced an anaphylactic reaction. The patient recovered. As of May 24, 2000, no further information was available. This event is considered medically important.
used to get the flu shot, but kept getting the flu; Initial information was received on 06-Dec-2021 regarding an unsolicited valid, social media, non-serious case received from a consumer.  This case involves a patient (unknown age and gender) who used to get the flu shot but kept getting the flu (Influenza) while receiving INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number not reported, and expiry date not provided] via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient used to get the flu shot but kept getting the flu (Influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It is unknown if the patient experienced any additional symptoms/events.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on batch number for this case.
None as of now. Dose was administered to wrong  patient , Everly received Pediarix and RotaTeq at 2 weeks of age instead of 2 months of age.
Some of the vaccine leaked out of syringe during administration. Checked site for guidance and reached out to CDC, but CDC closed. Patient is willing to return for revaccination if required once confirmed.
Information has been received from a physician concerning a nurse who on 17-DEC-2010 was splashed with some dose of ROTATEQ (Lot # not reported0 in her eye. The nurse stated that on 17-DEC-2010 she twisted off the top and it popped open like champagne cork and the vaccine shot in her eye and her eye started burning, eyewash was given, and it felt fine while they were given it to her, but after the eye wash, her eye started to burn again and it was red and puffy. She went to an urgent care facility and they gave her some type of drops to keep the eye wet. After the weekend her eye was fine and she had no loss of vision. Additional information has been requested.
Bruising, petechial started approximately 2-3 wks after vaccination. Evaluated in office 6/6/16 and found to have low platelets (thrombocytopenia).
4.5 x 4.5 cm circular erythematous blanchable warm to touch lesion on (L) ant lateral thigh.
PATIENT said she started having adverse reaction about 24 hours after the shot and she had Back pain, shoulder pain and neck pain and her BP was 200/100 pulse 107 and the symptoms lasted for about 24 hours and resolved on its own
She stated that she had corona virus and got the first dose of the Pfizer Covid vaccine.; got very sick; body ache; chills; high fever; This is a spontaneous report from a contactable consumer. A female patient of unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: unknown), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The consumer stated that the patient had corona virus and got the first dose of the Pfizer Covid vaccine. On an unspecified date, the patient got very sick, body ache, chills and high fever within 48 hours. The consumer asked if the patient could get the second dose of the Pfizer Covid vaccine. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Fever and chills developed about 8 pm that night. Chills subsided over night and fever continued until Saturday evening.
Received previous booster monovalent vaccine instead of the new bivalent booster, no adverse reaction noted the first 15 min of observation.
Developed shingles on upper right chest 5 days after vaccine. Treated with antiviral med.
Mild runny nose, cough and abd pain developed 4 days after H1N1 mist - Seen today at the office, Sx improving 10/21/09.
After the influenza injection I developed a small lump at the sight that was occasionally itchy.  It seems to have grown bigger and itchier after I had contracted covid-19 in September 2022.  I researched what it could be: and decided I should report it to Vaers.
injection site has itched every day; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (injection site has itched every day) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041120A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced INJECTION SITE PRURITUS (injection site has itched every day). At the time of the report, INJECTION SITE PRURITUS (injection site has itched every day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
severe pain in arm; Couldn't move arm and couldn't walk properly; Couldn't move arm and couldn't walk properly; This spontaneous report was received from a 60-year-old female patient who was reporting on herself. The patient did not have any pertinent medical history or concomitant therapies. Drug reactions or allergies included amoxicillin (+) clavulanate potassium (AUGMENTINE).  On 05-AUG-2019 at 15:00, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) intramuscular in the left arm (exact doses, lot number and expiration date were not reported) for prevention from pneumonia.  On 05-AUG-2019 at 21:00, the patient experienced severe pain in her arm. She said that she could not move her arm and that she could not walk properly. The patient tried using acetaminophen (TYLENOL) and ibuprofen (ADVIL) but they did not stop the pain. She went to the emergency room on 10-AUG-2019 and was prescribed medication that she had to take for five days. No laboratory diagnostics or studies were performed. The patient was no longer feeling pain after taking the medications. She recovered from the events on 15-AUG-2019.  The causal relationship between the events and the suspect drug was not reported.
Skin yellowing or being pale; This spontaneous case was reported by a consumer and describes the occurrence of YELLOW SKIN (Skin yellowing or being pale) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 09-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced YELLOW SKIN (Skin yellowing or being pale). At the time of the report, YELLOW SKIN (Skin yellowing or being pale) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Within two hours of the vaccine, my father was unable to walk, suffered severe weakness, and had severe shortness of breath.  The weakness, inability to walk, and shortness of breath lasted in a severe state for 48 hours.  After that, he continued to be unable to walk, suffered weakness and had shortness of breath until he died.  He never recovered the strength and vitality he had prior to the 2nd vaccine.  That 2nd shot shortened his life and killed him.
Starting feeling abdominal pain and shortness of breath. Later on diarrhea and vomiting. I also was unable to eat. At the time, I thought it would go away. I did not seek medical care. In the middle of May after the 2nd dose, I was admitted in the hospital.